Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

Trademark usage description

pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparat Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for the treatment of neurological diseases, namely, myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases.

Classification kind code

Mark Details

Serial Number

2239130

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 30^th Sep 2024	Registration Pending
Submitted for opposition 42 on 10^th Jul 2024	Advertised
Submitted for opposition 26 on 12^th Jun 2024	Approved
Submitted for opposition 27 on 12^th Jun 2024	Approval Notice Sent
Submitted for opposition 22 on 04^th Jun 2024	Search Recorded
Submitted for opposition 67 on 15^th Dec 2023	Agent Name Changed
Submitted for opposition 287 on 23^rd Feb 2023	Pre-Assessment Letter Sent
Submitted for opposition 30 on 10^th Feb 2023	Filed
Submitted for opposition 1 on 10^th Feb 2023	Created
Submitted for opposition 31 on 10^th Feb 2023	Formalized